Outset Medical CEO sells shares for tax withholding
Outset Medical, Inc. insider filing shows tax-related share sales by Chair and CEO Leslie Trigg.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Outset Medical, Inc. insider filing shows tax-related share sales by Chair and CEO Leslie Trigg. On January 20, 2026, Trigg sold 11,794 shares of common stock at $5.12 per share, followed by a sale of 2,120 shares at $5.05 per share on January 21, 2026.
According to the footnote, these transactions were the required number of shares sold to cover partial tax withholding obligations tied to the vesting of 32,552 RSU-based shares granted on June 10, 2025, executed as a "sell to cover" and not as discretionary trades. After these sales, Trigg directly beneficially owned 105,703 shares of common stock and indirectly held additional shares through trusts.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,120 | $5.05 | $11K |
| Sale | Common Stock | 11,794 | $5.12 | $60K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 32,552 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
AI-generated analysis. How Rhea-AI works. Not financial advice.